How a genetic parasite contributes to cancer development
- Researcher: Dr John LaCava
- Institution: The Rockefeller University, New York, USA
- Award Amount: £181,715 for 3 years from 1st March 2019
- Cancer Type: General Cancer Research
L1 retrotransposons play a role in cancer but little is known about how they act to promote and maintain cancer. In over 50 per cent of cases, the cancer genome contains more L1 retrotransposons then DNA from healthy cells, and the more the cancer genome contains, the more severe the disease seems to be.
The piece of genetic code contained within L1 retrotransposons carry the instructions that cells use to build two different proteins. And it’s only by interacting with other proteins in the cell that these proteins can make cancer cells grow and divide. Dr John LaCava and his team based at the Rockefeller University in New York, USA, are trying to unravel the network of interactions between these proteins to get a grasp of how L1 retrotransposons drive cancer. It is these discoveries that could open up new avenues for improving diagnosis and treatment of cancer.
The Research That Is Happening Right Now
Explore current projects to see how far-reaching our research is from a global perspective.
See the difference our research projects make.